The effects include reduced in the levels of inflammatory mediators such as IL-6 and TNF-α, improved pulmonary angiogenesis, ameliorated lung fibrosis and restored alveolar structures in BPD experimental models. Here, IL6 is linked to bronchopulmonary dysplasia.